Diabetes, Vol 44, Issue 4 441-445, Copyright © 1995 by American Diabetes Association

ARTICLES

Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli

SP Weinstein, T Paquin, A Pritsker and RS Haber
Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029.

To test the hypothesis that glucocorticoids inhibit muscle glucose transport apart from changes in early insulin-signaling events, we determined the effect of glucocorticoid treatment on the activation of glucose transport by both insulin and non-insulin-related stimuli (insulin-like growth factor [IGF] I and hypoxia) in rat skeletal muscle. Male Sprague-Dawley rats were treated with dexamethasone (Dex) (0.8 mg/kg for 2 days) and compared with pair-fed controls. 2-[3H]deoxyglucose (2-[3H]DG) uptake in isolated soleus muscles was measured under conditions in which uptake reflects glucose transport activity. In control muscles, 2-[3H]DG uptake was stimulated 10-fold by insulin (10 nmol/l) or IGF-I (50 nmol/l) and sixfold by hypoxia. Dex treatment decreased 2-[3H]DG uptake at all concentrations of insulin tested, reducing maximal insulin-stimulated 2-[3H]DG uptake by 41 +/- 11% (mean +/- SE, P < 0.05) and basal 2-[3H]DG uptake by 38 +/- 6% (P < 0.01). Dex treatment also inhibited 2-[3H]DG uptake at all concentrations of IGF-I tested, reducing maximal IGF-I-stimulated 2-[3H]DG uptake by 29 +/- 2% (P < 0.01), and decreased hypoxia-stimulated 2-[3H]DG uptake by 61% (P < 0.01). Dex treatment increased soleus GLUT4 protein content by 11%. Thus, Dex treatment reduces basal glucose transport and decreases the maximal response of skeletal muscle glucose transport to insulin, the related hormone IGF-I, and the non-insulin-related stimulus hypoxia. These findings support the hypothesis that, in addition to altering early insulin-signaling events, glucocorticoids may also act by inhibiting the glucose transport system, per se, perhaps by affecting GLUT4 subcellular trafficking.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. A. Asgeirsdottir, J. A. A. M. Kamps, H. I. Bakker, P. J. Zwiers, P. Heeringa, K. van der Weide, H. van Goor, A. H. Petersen, H. Morselt, H. E. Moorlag, et al. Site-Specific Inhibition of Glomerulonephritis Progression by Targeted Delivery of Dexamethasone to Glomerular Endothelium Mol. Pharmacol., July 1, 2007; 72(1): 121 - 131. [Abstract] [Full Text] [PDF]

				B. Laferrere, C. Abraham, M. Awad, S. Jean-Baptiste, A. B. Hart, P. Garcia-Lorda, P. Kokkoris, and C. D. Russell Inhibiting Endogenous Cortisol Blunts the Meal-Entrained Rise in Serum Leptin J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2232 - 2238. [Abstract] [Full Text] [PDF]

				K. Bouzakri, H. K.R. Karlsson, H. Vestergaard, S. Madsbad, E. Christiansen, and J. R. Zierath IRS-1 Serine Phosphorylation and Insulin Resistance in Skeletal Muscle From Pancreas Transplant Recipients Diabetes, March 1, 2006; 55(3): 785 - 791. [Abstract] [Full Text] [PDF]

				J. Ruzzin and J. Jensen Contraction activates glucose uptake and glycogen synthase normally in muscles from dexamethasone-treated rats Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E241 - E250. [Abstract] [Full Text] [PDF]

				P. B. Jacobson, T. W. von Geldern, L. Ohman, M. Osterland, J. Wang, B. Zinker, D. Wilcox, P. T. Nguyen, A. Mika, S. Fung, et al. Hepatic Glucocorticoid Receptor Antagonism Is Sufficient to Reduce Elevated Hepatic Glucose Output and Improve Glucose Control in Animal Models of Type 2 Diabetes J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 191 - 200. [Abstract] [Full Text] [PDF]

				J. K. Apple, E. B. Kegley, D. L. Galloway, T. J. Wistuba, and L. K. Rakes Duration of restraint and isolation stress as a model to study the dark-cutting condition in cattle J Anim Sci, May 1, 2005; 83(5): 1202 - 1214. [Abstract] [Full Text] [PDF]

				S. A. Summers and D. H. Nelson A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes, Metabolic Syndrome X, and Cushing's Syndrome Diabetes, March 1, 2005; 54(3): 591 - 602. [Abstract] [Full Text] [PDF]

				M. S. Rhee, A. Perianayagam, P. Chen, J. H. Youn, and A. A. McDonough Dexamethasone treatment causes resistance to insulin-stimulated cellular potassium uptake in the rat Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1229 - C1237. [Abstract] [Full Text] [PDF]

				H. Makimura, T. M. Mizuno, H. Bergen, and C. V. Mobbs Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1266 - E1271. [Abstract] [Full Text] [PDF]

				C. Severino, P. Brizzi, A. Solinas, G. Secchi, M. Maioli, and G. Tonolo Low-dose dexamethasone in the rat: a model to study insulin resistance Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E367 - E373. [Abstract] [Full Text] [PDF]

				M. J. Holness and M. C. Sugden Dexamethasone during Late Gestation Exacerbates Peripheral Insulin Resistance and Selectively Targets Glucose-Sensitive Functions in {beta} Cell and Liver Endocrinology, September 1, 2001; 142(9): 3742 - 3748. [Abstract] [Full Text] [PDF]

				S. Terada, T. Yokozeki, K. Kawanaka, K. Ogawa, M. Higuchi, O. Ezaki, and I. Tabata Effects of high-intensity swimming training on GLUT-4 and glucose transport activity in rat skeletal muscle J Appl Physiol, June 1, 2001; 90(6): 2019 - 2024. [Abstract] [Full Text] [PDF]

				R. M. Sapolsky, L. M. Romero, and A. U. Munck How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions Endocr. Rev., February 1, 2000; 21(1): 55 - 89. [Abstract] [Full Text]

				P. Schneiter and L. Tappy Kinetics of dexamethasone-induced alterations of glucose metabolism in healthy humans Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E806 - E813. [Abstract] [Full Text] [PDF]

				M. J. de Leon, T. McRae, H. Rusinek, A. Convit, S. De Santi, C. Tarshish, J. Golomb, N. Volkow, K. Daisley, N. Orentreich, et al. Cortisol Reduces Hippocampal Glucose Metabolism in Normal Elderly, but Not in Alzheimer's Disease J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3251 - 3259. [Abstract] [Full Text] [PDF]

				H. Masuzaki, Y. Ogawa, K. Hosoda, T. Miyawaki, I. Hanaoka, J. Hiraoka, A. Yasuno, H. Nishimura, Y. Yoshimasa, S. Nishi, et al. Glucocorticoid Regulation of Leptin Synthesis and Secretion in Humans: Elevated Plasma Leptin Levels in Cushing's Syndrome J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2542 - 2547. [Abstract] [Full Text] [PDF]